Results 341 to 350 of about 305,984 (384)

Role of NPPB for recovery post ventricular assist device in paediatric dilated cardiomyopathy: Single‐cell multiomics

ESC Heart Failure, EarlyView.
This study investigated factors associated with left ventricular recovery after LVAD implantation in paediatric dilated cardiomyopathy. Patients were classified into recovery and non‐recovery groups. Single‐nucleus sequencing revealed higher NPPB expression and altered apoptosis‐related pathways in the recovery group.
Yosuke Kugo, Takuji Kawamura, Akima Harada, Yuji Tominaga, Kenji Miki, Hidekazu Ishida, Takayoshi Ueno, Shigeru Miyagawa   +7 more
wiley   +1 more source

Mitochondrial cardiomyopathy with skeletal muscle myopathy caused by m.3260A > G mutation in MT-TL1 gene: a case report. [PDF]

J Med Case Rep
Kadiša A, Vereskuns R, Tarasovs M, Mičule I, Inashkina I.   +4 more
europepmc   +1 more source

Screening for cardiac conditions associated with sudden cardiac death in the young : external review against programme appraisal criteria for the UK National Screening Committee [PDF]

, 2019
Bradlow, William, Clarke, Aileen, Couper, Keith, Field, Richard A., Perkins, Gavin D., Poole, Kurtis, Royle, Pamela, Taylor-Phillips, Sian, Yeung, Joyce   +8 more
core  

Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy. [PDF]

Int J Mol Sci
Vo QD, Nakamura K, Saito Y, Akagi S, Miyoshi T, Yuasa S.   +5 more
europepmc   +1 more source

Early Detection of Treatment Response to Mavacamten in Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Regurgitation Using Magnetocardiography. [PDF]

Clin Case Rep
Suwalski P, Satilmis G, Reinthaler M, Landmesser U, Heidecker B.   +4 more
europepmc   +1 more source

Contemporary practice and resource availability for genetic testing in paediatric hypertrophic cardiomyopathy. [PDF]

J Med Genet
Sandmann C, Klaassen S, Kaski JP, Norrish G, International Paediatric Hypertrophic Cardiomyopathy Consortium investigators.   +4 more
europepmc   +1 more source

Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies. [PDF]

J Clin Med
Di Bella G, Micari A, Licordari R, Crea P, Colarusso L, Cusmà-Piccione M, Donato R, D'Angelo T, Dattilo G, Recupero A, de Gregorio C, Micari A, Donato Aquaro G.   +12 more
europepmc   +1 more source

Identifying PRKAG2 syndrome-a rare cause of wolff-Parkinson-white syndrome and left ventricular hypertrophy: a case report. [PDF]

Eur Heart J Case Rep
Jang JH, Baek YS, Jang WR, Kim DY, Shin SH.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies

European Journal of Heart Failure, 2023
Cardiomyopathies are a significant contributor to cardiovascular morbidity and mortality, mainly due to the development of heart failure and increased risk of sudden cardiac death (SCD).
Marija Polovina, Carsten Tschöpe, G. Rosano, M. Metra, F. Crea, W. Mullens, J. Bauersachs, K. Sliwa, R. D. de Boer, Dimitrios Farmakis, Thomas Thum, Domenico Corrado, Antoni Bayes Genis, B. Bozkurt, G. Filippatos, Andre Keren, H. Skouri, B. Moura, M. Volterrani, M. Abdelhamid, M. Ašanin, G. Krljanac, Milenko Tomić, G. Savarese, M. Adamo, Y. Lopatin, O. Chioncel, A. Coats, P. Seferovic   +28 more
semanticscholar   +1 more source

MRI of Cardiomyopathy

American Journal of Roentgenology, 2008
The aims of this article are to present the main features of MRI of cardiomyopathy and to show selected images of cardiomyopathies.Cardiomyopathy is a frequent reason for cardiac MRI evaluation, which is now considered the most appropriate imaging technique for the diagnosis and follow-up of this wide range of myocardial diseases.
Belloni, E, De Cobelli, F, Esposito, A, Mellone, R, PERSEGHIN, GIANLUCA, Canu, T, Del Maschio, A.   +6 more
openaire   +2 more sources